Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 27Mesothelioma, Malignant 14Solid Tumors 11Mesothelioma 10Advanced Solid Tumor 8Solid Tumor 5Advanced Solid Tumors 4Carcinoma, Non-Small-Cell Lung 3Solitary Fibrous Tumor, Pleural 2Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Metastatic Solid Tumors 1Malignant Neoplasmas 1Lung Neoplasms 1Locally Advanced or Metastatic Solid Tumours 1Cholangiocarcinoma of the Gallbladder 1Advanced Solid Tumours 1Advanced Solid Tumour 1Advanced Cancer 1Advance Solid Tumors 1Adult Solid Tumor 1

Interventions

entinostat 1Quality of Life 1Platinum 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Immunotherapy 1Gemcitabine 1Fentanyl 1Drug Therapy 1Cisplatin 1Biological Therapy 1BAY 1895344 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Penile Neoplasms × Gemcitabine × Other solid neoplasm × Clear all
NCT04491942 2026-04-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
74 enrolled
BreastGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡